Edition:
India

EyeGate Pharmaceuticals Inc (EYEG.OQ)

EYEG.OQ on NASDAQ Stock Exchange Capital Market

0.48USD
16 Nov 2018
Change (% chg)

$0.00 (+1.03%)
Prev Close
$0.47
Open
$0.47
Day's High
$0.49
Day's Low
$0.42
Volume
177,162
Avg. Vol
243,179
52-wk High
$1.38
52-wk Low
$0.28

Chart for

About

Eyegate Pharmaceuticals, Inc. is a clinical-stage specialty pharmaceutical company. The Company is focused on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye. The Company's lead product, EGP-437, incorporates a reformulated topically active corticosteroid, dexamethasone... (more)

Overall

Beta: --
Market Cap(Mil.): $20.99
Shares Outstanding(Mil.): 17.20
Dividend: --
Yield (%): --

Financials

  EYEG.OQ Industry Sector
P/E (TTM): -- 31.23 33.59
EPS (TTM): -1.30 -- --
ROI: -193.34 15.57 15.05
ROE: -241.44 16.94 16.62

Earnings vs. Estimates